Genetic Signature Predicts Outcome Of Pediatric Liver Cancer

Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children. The research, published by Cell Press in the December issue of the journal Cancer Cell, may lead to better treatments for pediatric liver cancers. Hepatoblastoma (HB), the most common liver cancer in children, is associated with abnormal activation of the Wnt/-catenin signaling pathway.

More: continued here

Filed under: Cancer on December 11th, 2008